We enjoyed reading the article from Guvendag Guven et al.(1) who looked into angle closure glaucoma (ACG) in pregnancy and its relationship with the drug ritodrine. We appreciate their efforts and here we would like to share our alternative ideas regarding the suggestion that ritodrine was one of the causes of ACG. Moreover, we would like to discuss other modalities of managing ACG in pregnant patients.Ritodrine is a selective beta-2-adrenoceptor agonist. In the human eye, beta receptors are mostly located in the ciliary process epithelium, followed by the iris sphincter. The iris dilator muscles contain mainly alpha receptors (2,3). Therefore it might be unlikely that the attack was related to ritodrine alone. Previous reports of ACG related to beta-2adrenergic agonist use, e.g. salbutamol, appeared to require a coexisting administration of a parasympathetic antagonist, such as ipratropium bromide. It was postulated that nebulized salbutamol caused an increase in intraocular pressure (IOP) by corneal absorption, with ciliary body beta-2-adrenergic receptor stimulation promoting aqueous humor secretion. Angle closure was exacerbated by pupil dilation caused by the parasympathetic inhibitory effect of ipratropium (4). We propose that further study would be needed to delineate the magnitude of effect of ritodrine alone on angle configuration.We agree with the authors that stress response and hospitalization in a dark room might cause pupil dilatation. These have been proposed as mechanisms of precipitating an ACG, and may indeed be partly responsible for the ACG attack in this pregnant woman, thus confounding the effects of ritodrine, if any.The authors chose glaucoma medications as their initial tools of management. We believe that one might need to be cautious with their use even though the pregnancy has reached the third trimester. The use of topical timolol has been reported to be associated with fetal cardiac arrhythmia (5). A newborn infant was reported to have developed metabolic acidosis, hypocalcemia, and hypomagnesemia because of maternal use of acetazolamide, pilocarpine, and timolol in pregnancy (6). Increasingly, glaucomatologists are using laser peripheral iridotomy (LPI) and argon laser peripheral iridoplasty (ALPI) as the initial management strategy as an alternative to glaucoma medications. In our experience with ACG attacks, the severity of corneal edema in the first few hours of the attack might not preclude a successful LPI. Even if LPI was not possible initially due to corneal edema, we could consider ALPI as the primary treatment modality, followed by second stage LPI (7). This obviates the need to use glaucoma medications with the potential adverse effects to the fetus.The authors mentioned certain factors that decrease the IOP in advancing pregnancy and ascribed them as protective mechanisms for ACG. However, we think that this might be true only for open angle glaucoma (OAG). ACG is a result of pupil block and angle closure, which has a typical IOP of around 50 Á/ 60 mmHg or above. This wil...